ACON

Aclarion, Inc.

Services-Medical LaboratoriesNasdaq<br>Emerging growth company

Total Trades

8

Buys

8

Sells

0

Largest Trade

$100K–$500K

Insiders

6

Institutional Funds

4

Inst. Value

$1K–$15K

Activist Filings

3

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Ness BrentCEOBUY<$1K10$6.20Dec 1, 2025
Thramann Jeffrey JohnExecutive ChairmanBUY$1K–$15K1$1000.00Feb 21, 2023
Ness BrentCEOBUY$1K–$15K19K$0.53Dec 30, 2022
Lorbiecki John PaulCFOBUY$1K–$15K22K$0.45Dec 29, 2022
Bond RyanChief Strategy Off…BUY$50K–$100K20K$2.80Apr 25, 2022
Wesemann WilliamDirectorBUY$15K–$50K11K$4.35Apr 25, 2022
Ness BrentCEOBUY$1K–$15K1K$4.35Apr 25, 2022
Neal David KDirectorBUY$100K–$500K34K$4.35Apr 25, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 4 funds holding

FundShares
UBS Group AG1K
Clear Street Group Inc.3
DANSKE BANK A/S1
CITIGROUP INC1

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

White Lion Capital, LLC

SC 13G/A · Dec 29, 2023

0.0%

0 shares

White Lion Capital, LLC 2

SC 13G · Oct 30, 2023

5.9%

48.8M shares

NuVasive, Inc.

SC 13G · Feb 3, 2023

14.4%

1.1M shares

View on Google Finance →